4//SEC Filing
von Moltke Lisa 4
Accession 0000950170-24-118424
CIK 0001609809other
Filed
Oct 28, 8:00 PM ET
Accepted
Oct 29, 6:33 PM ET
Size
9.8 KB
Accession
0000950170-24-118424
Insider Transaction Report
Form 4
von Moltke Lisa
See Remarks
Transactions
- Sale
Common Stock
2024-10-28$0.69/sh−4,334$2,991→ 30,423 total - Exercise/Conversion
Restricted Stock Units
2024-10-27−13,744→ 0 total→ Common Stock (13,744 underlying) - Exercise/Conversion
Common Stock
2024-10-27+13,744→ 34,757 total
Footnotes (4)
- [F1]On February 3, 2023, the reporting person was granted an award of 27,489 restricted stock units ("RSUs"), which vest in the form of shares of the Issuer's common stock in two substantially equal installments upon the satisfaction of certain performance criteria. On April 27, 2023 (the "Initial Milestone Date"), the Issuer's Administrator determined that the performance criteria for the first installment were met, resulting in the vesting and settlement of the award as to 13,745 RSUs on October 27, 2023, the date that was six months from the Initial Milestone Date. The remaining 13,744 RSUs vested and settled on October 27, 2024, the date that was eighteen months from the Initial Milestone Date.
- [F2]Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs do not have an expiration date.
- [F3]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 instruction adopted by the reporting person on July 2, 2023, solely with the intent to cover taxes in connection with the vesting of the restricted stock units.
- [F4]The price reported in column 4 is a weighted average of the sale prices. These shares were sold in multiple transactions at prices ranging from $0.69 to $ 0.7011, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
Seres Therapeutics, Inc.
CIK 0001609809
Entity typeother
Related Parties
1- filerCIK 0001808592
Filing Metadata
- Form type
- 4
- Filed
- Oct 28, 8:00 PM ET
- Accepted
- Oct 29, 6:33 PM ET
- Size
- 9.8 KB